# Enoxaparin Bioequivalence Study in Acute Coronary Syndrome Patients

> **NCT04552067** · PHASE1 · COMPLETED · sponsor: **University of Monastir** · enrollment: 172 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Lovenox
- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT04552067
- **Lead sponsor:** University of Monastir
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-04
- **Final completion:** 2014-01
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2020-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04552067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04552067, "Enoxaparin Bioequivalence Study in Acute Coronary Syndrome Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04552067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*